Brighton Jones’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$235K Sell
10,768
-158
-1% -$4.61K ﹤0.01% 1181
2026
Q2
$396K Buy
10,926
+26
+0.2% +$888 0.01% 911
2026
Q1
$360K Buy
+10,900
New +$461K 0.01% 837
2025
Q4
– Sell
-10,810
Closed -$378K – 223
2025
Q3
$378K Buy
10,810
+45
+0.4% +$1.56K 0.01% 730
2025
Q2
$318K Buy
10,765
+90
+0.8% +$2.57K 0.01% 699
2025
Q1
$319K Buy
10,675
+22
+0.2% +$672 0.01% 516
2024
Q4
$305K Sell
10,653
-29
-0.3% -$960 0.01% 515
2024
Q3
$413K Buy
10,682
+11
+0.1% +$392 0.02% 357
2024
Q2
$344K Sell
10,671
-100
-0.9% -$3.47K 0.01% 441
2024
Q1
$418K Buy
10,771
+129
+1% +$4.51K 0.02% 388
2023
Q4
$328K Hold
10,642
– – 0.01% 425
2023
Q3
$238K Hold
10,642
– – 0.01% 459
2023
Q2
$229K Hold
10,642
– – 0.01% 469
2023
Q1
$255K Hold
10,642
– – 0.01% 418
2022
Q4
$247K Hold
10,642
– – 0.01% 388
2022
Q3
$170K Buy
10,642
+49
+0.5% +$864 0.01% 432
2022
Q2
$188K Sell
10,593
-63
-0.6% -$1.06K 0.01% 436
2022
Q1
$217K Buy
10,656
+41
+0.4% +$775 0.01% 457
2021
Q4
$198K Buy
10,615
+22
+0.2% +$429 0.01% 501
2021
Q3
$209K Hold
10,593
– – 0.01% 447
2021
Q2
$250K Hold
10,593
– – 0.01% 398
2021
Q1
$251K Buy
+10,593
New +$252K 0.01% 351

Other funds holding COLL

Brighton Jones's COLL Position: Q3 2026 in Review

Brighton Jones reduced its Collegium Pharmaceutical (COLL) stake by 1.4% in Q3 2026, selling an estimated $4.61K and leaving 10,768 shares worth $235K. The position accounts for ﹤0.01% of the portfolio, ranked #1181.

Brighton Jones first reported a position in COLL in Q1 2021 and has held it in 22 quarters since. The position peaked at $418K in Q1 2024. 200 funds tracked by Wall St. Rank hold COLL as of Q3 2026.

  • Brighton Jones held 10,768 shares of Collegium Pharmaceutical worth $235K as of Q3 2026.
  • Brighton Jones sold 158 Collegium Pharmaceutical shares in Q3 2026, an estimated $4.61K.
  • Collegium Pharmaceutical made up ﹤0.01% of Brighton Jones's portfolio in Q3 2026, its #1181 holding.
  • Brighton Jones first reported a position in Collegium Pharmaceutical in Q1 2021 and has held it in 22 quarters since.
  • Brighton Jones's Collegium Pharmaceutical position peaked at $418K in Q1 2024.
  • 200 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.